(Albany, USA) DelveInsight’s “Osteoarthritis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Osteoarthritis, historical and forecasted epidemiology as well as the Osteoarthritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

The Osteoarthritis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Osteoarthritis market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Osteoarthritis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Osteoarthritis market.

 

Request for a Free Sample Report @ Osteoarthritis Market Forecast

 

Some facts of the Osteoarthritis Market Report are:

• According to DelveInsight, Osteoarthritis market size is expected to grow at a decent CAGR by 2032.
• Leading Osteoarthritis companies working in the market are Novartis, Ampio Pharmaceuticals, Taiwan Liposome Company, Centrexion Therapeutics, Biosplice Therapeutics, Organogenesis, Kolon Tissuegene, Paradigm Biopharma, Novo Nordisk, Amzell, Nature Cell, Tissuetech, Techfields Pharma, Sorrento Therapeutics, Merck Kgaa, Anika Therapeutics, Trialspark, Akl Research And Development, Flexion Therapeutics, OliPass Corporation, Pacira BioSciences, Medipost, Medivir, and others.
• Key Osteoarthritis Therapies expected to launch in the market are ZILRETTA, CINGAL, TRIVISC, VISCO-3, LNA043, ReNu (Amniotic Suspension Allograft), JointStem, CNTX-4975, and others.
• In Jan 2023, OliPass Corporation announced a study which is designed to evaluate the efficacy, safety and tolerability of OLP-1002 Subcutaneous (SC) injections for reducing moderate to severe pain due to osteoarthritis in a hip and/or knee joint.
• In October 2022, Eupraxia Pharmaceuticals Inc. announced updates to its Phase II trial, which is evaluating EP-104IAR’s efficacy and safety for the treatment of osteoarthritis (“OA”) of the knee.Eupraxia announced that its ongoing Phase II study has successfully completed all DSMB reviews, with no drug-related Serious Adverse Events noted and a clean safety profile.
• In September 2022, KiOmed Pharma and Hansoh Pharmaceutical Group Company Limited announced a license agreement for the development and commercialization of KiOmedinevsOne, a carboxymethyl chitosan injection that has been launched in Europe for the treatment of knee osteoarthritis, in China’s mainland, Macau and Taiwan (the territory).Under the terms of the agreement, KiOmed will receive an upfront payment and will be eligible to receive development, regulatory and commercial milestones of up to € 66 million, as well as tiered royalties on future product sales.

 

Osteoarthritis Overview

Osteoarthritis is a degenerative joint disease characterized by the breakdown of cartilage, which cushions the ends of bones in joints. It is the most common form of arthritis and typically affects weight-bearing joints such as the knees, hips, and spine, as well as the hands. Osteoarthritis causes pain, stiffness, and reduced joint mobility, often leading to difficulties in daily activities. Risk factors include aging, obesity, joint injuries, and genetics. While there is no cure for osteoarthritis, treatment options focus on managing symptoms, improving joint function, and maintaining a good quality of life through pain relief, exercise, weight management, and sometimes surgery.

 

Learn more about Osteoarthritis treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ https://www.delveinsight.com/sample-request/osteoarthritis-market

 

Osteoarthritis Market

The Osteoarthritis market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Osteoarthritis market trends by analyzing the impact of current Osteoarthritis therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.

This segment gives a thorough detail of the Osteoarthritis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Osteoarthritis market data are presented with relevant tables and graphs to give a clear view of the market at first sight. 

According to DelveInsight, the Osteoarthritis market in 7MM is expected to witness a major change in the study period 2019-2032.

 

Osteoarthritis Epidemiology

The Osteoarthritis epidemiology section provides insights into the historical and current Osteoarthritis patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Osteoarthritis market report also provides the diagnosed patient pool, trends, and assumptions. 

 

Explore more about Osteoarthritis Epidemiology @ https://www.delveinsight.com/sample-request/osteoarthritis-market

 

Osteoarthritis Drugs Uptake

This section focuses on the uptake rate of the potential Osteoarthritis drugs recently launched in the Osteoarthritis market or expected to be launched in 2019-2032. The analysis covers the Osteoarthritis market uptake by drugs, patient uptake by therapies, and sales of each drug.

Osteoarthritis Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Osteoarthritis market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

 

Osteoarthritis Pipeline Development Activities

The Osteoarthritis report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Osteoarthritis key players involved in developing targeted therapeutics.

 

Request for a sample report to understand more about the Osteoarthritis pipeline development activities @ https://www.delveinsight.com/sample-request/osteoarthritis-market

 

Osteoarthritis Therapeutics Assessment

Major key companies are working proactively in the Osteoarthritis Therapeutics market to develop novel therapies which will drive the Osteoarthritis treatment markets in the upcoming years are Novartis, Ampio Pharmaceuticals, Taiwan Liposome Company, Centrexion Therapeutics, Biosplice Therapeutics, Organogenesis, Kolon Tissuegene, Paradigm Biopharma, Novo Nordisk, Amzell, Nature Cell, Tissuetech, Techfields Pharma, Sorrento Therapeutics, Merck Kgaa, Anika Therapeutics, Trialspark, Akl Research And Development, Flexion Therapeutics, OliPass Corporation, Pacira BioSciences, Medipost, Medivir, and others.

 

Learn more about the emerging Osteoarthritis therapies & key companies @ https://www.delveinsight.com/sample-request/osteoarthritis-market

 

Osteoarthritis Report Key Insights

1. Osteoarthritis Patient Population

2. Osteoarthritis Market Size and Trends

3. Key Cross Competition in the Osteoarthritis Market

4. Osteoarthritis Market Dynamics (Key Drivers and Barriers)

5. Osteoarthritis Market Opportunities

6. Osteoarthritis Therapeutic Approaches

7. Osteoarthritis Pipeline Analysis

8. Osteoarthritis Current Treatment Practices/Algorithm

9. Impact of Emerging Therapies on the Osteoarthritis Market

 

Table of Contents

1. Key Insights

2. Executive Summary

3. Osteoarthritis Competitive Intelligence Analysis

4. Osteoarthritis Market Overview at a Glance

5. Osteoarthritis Disease Background and Overview

6. Osteoarthritis Patient Journey

7. Osteoarthritis Epidemiology and Patient Population

8. Osteoarthritis Treatment Algorithm, Current Treatment, and Medical Practices

9. Osteoarthritis Unmet Needs

10. Key Endpoints of Osteoarthritis Treatment

11. Osteoarthritis Marketed Products

12. Osteoarthritis Emerging Therapies

13. Osteoarthritis Seven Major Market Analysis

14. Attribute Analysis

15. Osteoarthritis Market Outlook (7 major markets)

16. Osteoarthritis Access and Reimbursement Overview

17. KOL Views on the Osteoarthritis Market

18. Osteoarthritis Market Drivers

19. Osteoarthritis Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

 

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting